STAT - Reporting from the frontiers of health and medicine

Health

Biotech

First Opinion

By Kevin Outterson and John Rex

Health Antibody drugs could be one of the best weapons against Covid-19. But will they matter?
Special Report Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Health Tech With Livongo’s arsenal of health devices, Teladoc is poised to move into remote monitoring
Health Inspired by llamas’ unique antibodies, scientists create a potent anti-coronavirus molecule
First Opinion With Covid-19 halting clinical trials, wearables could be key — but data ‘wild west’ gets in the way

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Out-of-pocket spending on specialty drugs dropped dramatically after states capped costs
Seres announces positive late-stage results for its microbe-based drug
Seizing on India’s lax standards for Covid-19 drugs, critics push for an overhaul on transparency

Health

Health Tech

Health

Health

By Ron Winslow

Special Report

Health

Health Winter is coming: Why America’s window of opportunity to beat back Covid-19 is closing
Health Inspired by llamas’ unique antibodies, scientists create a potent anti-coronavirus molecule
Health Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder
Health The Covid-19 Tracker
Health Antibody drugs could be one of the best weapons against Covid-19. But will they matter?
Health ‘We don’t actually have that answer yet’: WHO clarifies comments on asymptomatic spread of Covid-19
Health Covid-19 infections leave an impact on the heart, raising concerns about lasting damage
Biotech 4 questions for neurology startups as venture investors pour millions into the field